Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Leukemia

Free Subscription 30.03.2026 1 Acta Haematol 6 Ann Hematol 1 Biochem Biophys Res Commun 1 Blood 1 BMC Cancer 1 Bone Marrow Transplant 1 Cancer 1 Eur J Haematol 2 Int J Hematol 1 J Biol Chem 1 J Immunol 1 J Pediatr Hematol Oncol 4 Leuk Lymphoma 4 Leuk Res 6 Leukemia 1 N Engl J Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Haematol

1. MAYER K, Birk L, Schwab K, Schmidt-Wolf IGH, et al
   Dose Reduced Induction Therapy (A)-AIDA in Patients with Acute Myeloid Leukemia, Being Unfit for Standard 7+3 Chemotherapy and Literature Review of Acute Myeloid Leukemia Treatment in Unfit/Older AML Patients.
   Acta Haematol. 2026;149:155-167.
   PubMed         Abstract available
   
   

   
   Ann Hematol

2. WERK J, Baden D, Shaforostova I, Mikesch JH, et al
   Beta-blocker use and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
   Ann Hematol. 2026;105:205.
   PubMed         Abstract available
   
   
3. WANG S, Zang H, Du W, Guo L, et al
   Risk factors for leukemic transformation in myeloproliferative neoplasms and prognostic factors in secondary acute myeloid leukemia: an exploratory analysis of the SEER database.
   Ann Hematol. 2026;105:204.
   PubMed         Abstract available
   
   
4. RIVERA-PEREZ C, Morgades M, Alonso-Saladrigues A, Montesinos P, et al
   Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups.
   Ann Hematol. 2026;105:203.
   PubMed         Abstract available
   
   
5. PATEL E, Singh A, Beach D, Morrissette J, et al
   Myeloid dermatosis with features of sweet syndrome and leukemia cutis: a case report.
   Ann Hematol. 2026;105:194.
   PubMed         Abstract available
   
   
6. LIU S, Zhou B, Qian C, Li Z, et al
   The clinical characteristics and prognosis analysis of acute B-cell lymphoblastic leukemia with MEF2D fusions.
   Ann Hematol. 2026;105:200.
   PubMed         Abstract available
   
   
7. LIU N, Ma YR, Pang JN, Sun M-, et al
   2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis.
   Ann Hematol. 2026;105:199.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

8. CHEN CW, Lin YF, Yeh YY, Huang NK, et al
   Dual-specificity phosphatase 21 enhances the sensitivity of imatinib-resistant chronic myeloid leukemia cells to ponatinib through GATA-1-mediated erythroid differentiation.
   Biochem Biophys Res Commun. 2026;814:153646.
   PubMed         Abstract available
   
   

   
   Blood

9. SHILOH R, Izraeli S
   Cracking the nut of NUTM1 rearrangements in infant leukemia.
   Blood. 2026;147:1383-1384.
   PubMed        
   
   

   
   BMC Cancer

10. ABREU RS, Maior KS, Souza IML, Paes JF, et al
    Real-life data of patients with chronic myeloid leukemia in Amazonas.
    BMC Cancer. 2026 Mar 25. doi: 10.1186/s12885-026-15843.
    PubMed        
    
    

    
    Bone Marrow Transplant

11. NAGLER A, Swoboda R, Ferhat AT, Blaise D, et al
    Peripheral blood stem cells versus bone marrow graft for non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT.
    Bone Marrow Transplant. 2026 Mar 25. doi: 10.1038/s41409-026-02823.
    PubMed         Abstract available
    
    

    
    Cancer

12. LIU L, Shi Y, Wang L, Maleki Goli M, et al
    Combined prognostic impact of complex karyotype and KIT mutations refines risk stratification in t(8;21) acute myeloid leukemia.
    Cancer. 2026;132:e70370.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

13. GOULARTE MN, Miyamoto MH, de Lacerda MP
    Venetoclax Combined With Intensive Chemotherapy Regimens for Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Systematic Review and Single-Arm Meta-Analysis.
    Eur J Haematol. 2026 Mar 25. doi: 10.1111/ejh.70175.
    PubMed         Abstract available
    
    

    
    Int J Hematol

14. YOSHINARI H, Kawahara Y, Niijima H, Aoki S, et al
    Acute megakaryoblastic leukemia with RBM15::MKL1 fusion presenting as neonatal acute liver failure: rescued by living-donor liver transplantation.
    Int J Hematol. 2026 Mar 24. doi: 10.1007/s12185-026-04194.
    PubMed         Abstract available
    
    
15. NOSAKA K
    Recent progress in T-cell malignancies including adult T-cell leukemia-lymphoma.
    Int J Hematol. 2026 Mar 23. doi: 10.1007/s12185-026-04197.
    PubMed         Abstract available
    
    

    
    J Biol Chem

16. FAUST JR, Hamill D, Kolb EA, Stevens AM, et al
    Mesothelin Promotes Acute Myeloid Leukemia Progression through LYN-dependent Signaling.
    J Biol Chem. 2026 Mar 20:111390. doi: 10.1016/j.jbc.2026.111390.
    PubMed         Abstract available
    
    

    
    J Immunol

17. MILLER BA, Horan K, Abbott DW, Pearlman E, et al
    Perturbation of azurophilic granule integrity drives NLRP3-independent IL-1beta processing and release in neutrophils.
    J Immunol. 2026;215:vkag033.
    PubMed         Abstract available
    
    

    
    J Pediatr Hematol Oncol

18. GOLDENSOPH A, Mauro J, Freudenthal J, Burns AN, et al
    Prophylactic Levofloxacin Use in Oncology and Hematopoietic Stem Cell Transplants for Children Under 2 Years of Age.
    J Pediatr Hematol Oncol. 2026;48:e118-e127.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

19. LEVY V, Lengline E, Chevret S
    When evaluating targeted therapies in chronic lymphocytic leukemia, the absolute measure of treatment effect should be preferred.
    Leuk Lymphoma. 2026 Mar 24:1-10. doi: 10.1080/10428194.2026.2647950.
    PubMed         Abstract available
    
    
20. HOFSTETTER L, Shimony S, Sherban A, Raanani P, et al
    Pericardial effusion and tamponade as a rare cardiac toxicity of covalent BTK inhibitors in CLL-a multi-modality study.
    Leuk Lymphoma. 2026;67:860-867.
    PubMed         Abstract available
    
    
21. CHAUHAN A, Singh K, Chaturvedi CP, Rai AK, et al
    BET bromodomain inhibition: a potential therapeutic avenue in MEF2D-HNRNPUL1-rearranged B-cell acute lymphoblastic leukaemia.
    Leuk Lymphoma. 2026;67:868-879.
    PubMed         Abstract available
    
    
22. FLEROVA E, Chai J, Choudhuri J, Gong JZ, et al
    Correlation of EZH2 and related signaling molecules p-STAT3, p-ERK1/2, and MYC overexpression with H3K27 trimethylation associates differently to disease progression in JAK2 mutation -positive and -negative myeloid neoplasms.
    Leuk Lymphoma. 2026;67:832-845.
    PubMed         Abstract available
    
    

    
    Leuk Res

23. WANG N, Feng Z, Zheng H, Chen X, et al
    Diagnostic updates and research advances in AML-MR: Integrating molecular genetics and immune mechanisms.
    Leuk Res. 2026;163:108200.
    PubMed         Abstract available
    
    
24. LU W, He Z, Huang X
    Integrative transcriptomic and machine learning analysis identifies core immune genes and pathways driving graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Leuk Res. 2026;163:108201.
    PubMed         Abstract available
    
    
25. BRANDWEIN J, Szkotak A, Page D, Wang P, et al
    Impact of measurable residual disease on outcomes using a modified DFCI protocol for adults with BCR-ABL negative acute lymphoblastic leukemia.
    Leuk Res. 2026;164:108206.
    PubMed         Abstract available
    
    
26. ARAI Y, Katagiri S, Chi S, Yoshimoto G, et al
    Bi-directional association between RUNX1::RUNX1T1 and KIT mutations in acute myeloid leukemia: A multicenter genomic profiling study.
    Leuk Res. 2026;164:108207.
    PubMed         Abstract available
    
    

    
    Leukemia

27. NICKELS EM, Morimoto LM, Kang AY, Metayer C, et al
    The impact of periconceptional folate on the DNA methylome of acute lymphoblastic leukemia.
    Leukemia. 2026 Mar 24. doi: 10.1038/s41375-026-02866.
    PubMed         Abstract available
    
    
28. FASCI A, Vallone FE, Nabelsi N, Viry E, et al
    Functional cooperation between the B-cell receptor and NOTCH1 in regulating metabolic reprogramming in chronic lymphocytic leukemia.
    Leukemia. 2026 Mar 23. doi: 10.1038/s41375-026-02912.
    PubMed         Abstract available
    
    
29. TU Y, Cai X, Tao Z, Zhang R, et al
    Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicity.
    Leukemia. 2026 Mar 25. doi: 10.1038/s41375-026-02925.
    PubMed         Abstract available
    
    
30. ARYAL S, Curtiss BM, Zhou X, Lu R, et al
    A Perturb-seq map of a differentiation hub reveals synergistic vulnerabilities in KMT2A-rearranged acute myeloid leukemia.
    Leukemia. 2026 Mar 25. doi: 10.1038/s41375-026-02917.
    PubMed         Abstract available
    
    
31. VASSEUR L, Duchmann M, Duployez N, Raffoux E, et al
    Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.
    Leukemia. 2026 Mar 26. doi: 10.1038/s41375-026-02900.
    PubMed         Abstract available
    
    
32. LI YR, Shen X, Chen Y, Zhu Y, et al
    Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia.
    Leukemia. 2026 Mar 26. doi: 10.1038/s41375-026-02930.
    PubMed         Abstract available
    
    

    
    N Engl J Med

33. ANNAMALAY A, Garcia Gonzalez I, Forsyth C, Jenkins I, et al
    Treatment-free Remission in Chronic Myeloid Leukemia in Low- and Middle-Income Countries.
    N Engl J Med. 2026;394:1238-1240.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum